Back to Search Start Over

Brucine alleviates fibroblast‐like synoviocytes dysfunction and inflammation by regulating YY1 during rheumatoid arthritis.

Authors :
Zhang, Qian
Wang, Gaodan
Xu, Bin
Source :
Chemical Biology & Drug Design; Mar2024, Vol. 103 Issue 3, p1-12, 12p
Publication Year :
2024

Abstract

Brucine is a weak alkaline indole alkaloid with wide pharmacological activities and has been identified to protect against rheumatoid arthritis (RA) process. Circular RNAs (circRNAs) are also reported to be involved in the pathogenesis of RA. Here, we aimed to probe the role and mechanism of Brucine and circ_0139658 in RA progression. The fibroblast‐like synoviocytes of RA (RA‐FLSs) were isolated for functional analysis. Cell proliferation, apoptosis, invasion, migration, as well as inflammatory response were evaluated by CCK‐8 assay, EdU assay, flow cytometry, transwell assay, and ELISA analysis, respectively. qRT‐PCR and western blotting analyses were utilized to measure the levels of genes and proteins. The binding between miR‐653‐5p and circ_0139658 or Yin Yang 1 (YY1), was verified using dual‐luciferase reporter and RNA pull‐down assays. Brucine suppressed the proliferation, migration, and invasion of RA‐FLSs, and alleviated inflammation by reducing the release of pro‐inflammatory factors and macrophage M1 polarization. RA‐FLSs showed increased circ_0139658 and YY1 levels and decreased miR‐653‐5p levels. Circ_0139658 is directly bound to miR‐653‐5p to regulate YY1 expression. Brucine treatment suppressed circ_0139658 and YY1 expression but increased YY1 expression in RA‐FLSs. Functionally, circ_0139658 overexpression reversed the suppressing effects of Brucine on RA‐FLS dysfunction and inflammation. Moreover, circ_0139658 silencing alleviated the dysfunction and inflammation in RA‐FLSs, which were reverted by YY1 overexpression. Brucine suppressed the proliferation, migration, invasion, and inflammation in RA‐FLSs by decreasing YY1 via circ_0139658/miR‐653‐5p axis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17470277
Volume :
103
Issue :
3
Database :
Complementary Index
Journal :
Chemical Biology & Drug Design
Publication Type :
Academic Journal
Accession number :
176295119
Full Text :
https://doi.org/10.1111/cbdd.14472